Medchemexpress LLC 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone | 274925-86-9 | MFCD09954136 | 99.9% | 273.24 g·mol-1 | C14H11NO5 | 10 MG

Supplier:  Medchemexpress LLC HY10640510MG

Nebicapone is a reversible catechol-O-methyltransferase (COMT) inhibitor supplied as a research-grade small molecule for preclinical pharmacology and biochemical studies. It acts mainly in the periphery to reduce conversion of L-DOPA to 3-O-methyl-DOPA and is used in experiments modeling COMT modulation and Parkinson's disease-related pathways.

• Reversible COMT inhibitor with peripheral activity.
• Reduces biotransformation of L-DOPA to 3-O-methyl-DOPA.
• Suitable for in vitro and in vivo pharmacology studies.
• Provided as solid doses (for example, 10 mg) and a 10 mM DMSO solution.
• High purity (99.89%) for research applications.
• Soluble in DMSO at ≥100 mg/mL; in vivo formulation protocols available.
• Store solid at 4°C protected from light; in solvent store at -80°C for long term or -20°C for short term.

Catalog No. 50-002-41917